학술논문

The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective
Document Type
Artikel
Source
American journal of cardiovascular drugs : drugs, devices, and other interventions. 24(1):117-127
Subject
Medicin och hälsovetenskap
Language
English
English
ISSN
1179-187X